Epizyme Stock Net Income

Summary

EPZMDelisted Stock

USD 1.47 0.00 0.00%

Epizyme fundamentals help investors to digest information that contributes to Epizyme's financial success or failures. It also enables traders to predict the movement of Epizyme Stock. The fundamental analysis module provides a way to measure Epizyme's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Epizyme stock.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Epizyme Company Net Income Analysis

Epizyme's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Net Income

(Rev + Gain)

-

(Exp + Loss)

More About Net Income | All Equity Analysis

Current Epizyme Net Income

(236.35 M)

Most of Epizyme's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Epizyme is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.

Competition

Based on the recorded statements, Epizyme reported net income of (236.35 Million). This is 169.25% lower than that of the Healthcare sector and significantly lower than that of the Biotechnology industry. The net income for all United States stocks is 141.39% higher than that of the company.

Epizyme Net Income Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Epizyme's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Epizyme could also be used in its relative valuation, which is a method of valuing Epizyme by comparing valuation metrics of similar companies.

Epizyme is currently under evaluation in net income category among related companies.

Epizyme Fundamentals

	Return On Equity	-352.37
	Return On Asset	-38.96
	Operating Margin	(582.15) %
	Current Valuation	334.85 M
	Shares Outstanding	103.89 M
	Shares Owned By Insiders	0.58 %
	Shares Owned By Institutions	90.32 %
	Number Of Shares Shorted	5.49 M
	Price To Earning	(7.76) X
	Price To Book	1.00 X
	Price To Sales	3.97 X
	Revenue	38.49 M
	Gross Profit	18.57 M
	EBITDA	(218.82 M)
	Net Income	(236.35 M)
	Cash And Equivalents	199.73 M
	Cash Per Share	1.21 X
	Total Debt	254.44 M
	Current Ratio	5.87 X
	Book Value Per Share	1.46 X
	Cash Flow From Operations	(210.47 M)
	Short Ratio	0.88 X
	Earnings Per Share	(2.29) X
	Price To Earnings To Growth	(0.03) X
	Number Of Employees	250
	Beta	-0.45
	Market Capitalization	152.73 M
	Total Asset	217.9 M
	Retained Earnings	(776.94 M)
	Working Capital	194.61 M
	Current Asset	213.06 M
	Current Liabilities	18.45 M
	Z Score	-7.5

About Epizyme Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Epizyme's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Epizyme using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Epizyme based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Pair Trading with Epizyme

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Epizyme position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Epizyme will appreciate offsetting losses from the drop in the long position's value.

Moving together with Epizyme Stock

0.82	NVO	Novo Nordisk AS Financial Report 2nd of May 2024	Pair Corr
0.8	NONOF	Novo Nordisk AS	Pair Corr

Moving against Epizyme Stock

0.88	ZTLLF	Zonetail	Pair Corr
0.74	VRTX	Vertex Pharmaceuticals Financial Report 6th of May 2024	Pair Corr
0.68	WXIBF	WuXi Biologics	Pair Corr
0.63	CSLLY	CSL	Pair Corr
0.62	GLABF	Gemina Laboratories	Pair Corr

The ability to find closely correlated positions to Epizyme could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Epizyme when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Epizyme - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Epizyme to buy it.

The correlation of Epizyme is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Epizyme moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Epizyme moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Epizyme can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.

Note that the Epizyme information on this page should be used as a complementary analysis to other Epizyme's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Consideration for investing in Epizyme Stock

If you are still planning to invest in Epizyme check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Epizyme's history and understand the potential risks before investing.

	Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
	Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios.
	Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk
	Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
	Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC